日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processes.

GII.17 诺如病毒在 2020 年代由于动态和适应性进化过程而再次出现。

Tohma Kentaro, Jacobsen Sonja, Altmann Britta, Kendra Joseph A, Landivar Michael, De La O William E, Fernandez-Garcia Maria Dolores, Gomes Karina A, Chudnovsky Sophia, Ford-Siltz Lauren A, Pilewski Kelsey A, Gao Yamei, Mazo Ilya, Niendorf Sandra, Parra Gabriel I

Controlled environment agriculture: An opportunity to strengthen interagency research collaboration in the US government

可控环境农业:加强美国政府各部门间研究合作的契机

Boyd, Abigail P; Zankowski, Paul; Wheeler, Raymond; Stokes-Draut, Jennifer R; Chudnovsky, Yaroslav; Ingram, David; Tijerina, Mary; Mickens, Matthew; Steward, Darlene; Armstrong, Kristina; Boggs, Ashley S P; Neely, Benjamin A; Lunney, Joan K; Luo, Yaguang

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies

一项针对晚期/转移性实体瘤或复发/难治性血液系统恶性肿瘤患者的SUMO化抑制剂Subasumstat的首次人体研究

Dejan Juric ,Daniel Anderson ,Afshin Dowlati ,Jordi Rodon ,Iwona Lugowska ,Sławomir Mańdziuk ,Yuqin Song ,Feng Jung Sherida H Woei-A-Jin ,Marc André ,Joanna Góra Tybor ,José-Ángel Hernández-Rivas ,Razelle Kurzrock ,Armando López-Guillermo ,David Schröder ,Rafal Stec ,Allison Berger ,Bo Chao ,Aleksander Chudnovsky ,John P Gibbs ,Tao Long ,Dina Stroopinsky ,Qi Dong ,Anthony J Olszanski

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

肾切除术后局限性肾细胞癌辅助治疗中,纳武利尤单抗联合伊匹木单抗与安慰剂的疗效比较(CheckMate 914):一项双盲、随机、3期临床试验

Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez Estévez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial

研究总结:肾切除术后局限性肾细胞癌辅助治疗中,纳武利尤单抗联合伊匹木单抗对比安慰剂(CheckMate 914):一项双盲、随机、3期试验

Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez Estévez, Sergio; Simsek, Burcin; Spiridigliozzi, Julia; Chudnovsky, Aleksander; Bex, Axel

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

阿维鲁单抗联合阿昔替尼与舒尼替尼治疗肉瘤样肾细胞癌的疗效及相关性分析:一项随机临床试验的事后分析

Choueiri, T K; Larkin, J; Pal, S; Motzer, R J; Rini, B I; Venugopal, B; Alekseev, B; Miyake, H; Gravis, G; Bilen, M A; Hariharan, S; Chudnovsky, A; Ching, K A; Mu, X J; Mariani, M; Robbins, P B; Huang, B; di Pietro, A; Albiges, L

Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]

对“avelumab 联合 axitinib 与舒尼替尼治疗肉瘤样肾细胞癌的疗效和相关性分析:一项随机临床试验的事后分析”的勘误:[ESMO Open 第 6 卷,第 3 期,2021 年 6 月,100101]

Choueiri, T K; Larkin, J; Pal, S; Motzer, R J; Rini, B I; Venugopal, B; Alekseev, B; Miyake, H; Gravis, G; Bilen, M A; Hariharan, S; Chudnovsky, A; Ching, K A; Mu, X J; Mariani, M; Robbins, P B; Huang, B; di Pietro, A; Albiges, L

Not far enough: Public health policies to combat COVID-19 in Mexico's states

力度不够:墨西哥各州应对新冠肺炎的公共卫生政策

Knaul, Felicia; Arreola-Ornelas, Héctor; Porteny, Thalia; Touchton, Michael; Sánchez-Talanquer, Mariano; Méndez, Óscar; Chertorivski, Salomón; Ortega, Sonia; Chudnovsky, Mariana; Kuri, Pablo